VitaNova Life Sciences Corporation Deferred Tax Assets, Valuation Allowance
VitaNova Life Sciences Corporation (VNOV) had Deferred Tax Assets, Valuation Allowance of $25.31 thousand as of 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2026-09-14
- 2026-07-31: Deferred Tax Assets, Valuation Allowance $25.31K.
- 2026-04-30: Deferred Tax Assets, Valuation Allowance $0.00.
- 2026-01-31: Deferred Tax Assets, Valuation Allowance $4.45K.
- 2025-10-31: Deferred Tax Assets, Valuation Allowance $45.32K.
| Period end | Deferred Tax Assets, Valuation Allowance | Deferred Tax Assets, Valuation Allowance as first filed |
|---|---|---|
| 2026-07-31 | $25.31K 10-Q · filed 2026-09-14 | |
| 2026-04-30 | $0.00 10-Q · filed 2026-09-14 | |
| 2026-01-31 | $4.45K 10-Q · filed 2026-03-16 | |
| 2025-10-31 | $45.32K 10-Q · filed 2025-12-15 | |
| 2025-07-31 | $17.40K 10-Q · filed 2025-09-12 | |
| 2025-04-30 | $102.61K 10-K · filed 2026-07-29 | |
| 2025-01-31 | $43.84K 10-Q · filed 2025-03-17 | |
| 2024-12-31 | $31.70K 10-Q · filed 2024-03-11 | |
| 2024-10-31 | $31.92K 10-Q · filed 2024-12-13 | |
| 2024-07-31 | $19.18K 10-Q · filed 2024-09-10 | |
| 2024-04-30 | $46.97K 10-K · filed 2025-07-24 | |
| 2023-10-31 | $32.95K 10-Q · filed 2023-12-15 | |
| 2023-07-31 | $31.11K 10-Q · filed 2023-09-14 | |
| 2023-04-30 | $26.02K 10-K · filed 2024-07-29 | |
| 2023-04-03 | $26.02K 10-Q · filed 2024-03-11 | |
| 2023-01-31 | $6.97K 10-Q · filed 2023-02-16 | |
| 2022-10-31 | $1.81K 10-Q · filed 2022-11-14 | |
| 2022-07-31 | $2.36K 10-Q · filed 2022-09-01 | |
| 2022-04-30 | $20.93K 10-K · filed 2023-05-15 | $2.81K 10-K · filed 2022-05-16 |
| 2022-01-31 | $15.30K 10-Q · filed 2022-02-17 | |
| 2021-10-31 | $17.18K 10-Q · filed 2021-11-10 | |
| 2021-07-31 | $20.33K 10-Q · filed 2021-08-20 | |
| 2021-04-30 | $50.27K 10-K · filed 2022-05-16 | |
| 2021-01-31 | $44.90K 10-Q · filed 2021-06-21 | |
| 2020-10-31 | $44.29K 10-Q · filed 2020-11-25 | |
| 2020-07-31 | $41.69K 10-Q · filed 2020-09-18 | |
| 2020-04-30 | $39.33K 10-K · filed 2021-07-01 | |
| 2020-01-31 | $33.80K 10-Q · filed 2020-03-20 | |
| 2019-10-31 | $32.41K 10-Q · filed 2019-12-06 | |
| 2019-07-31 | $28.31K 10-Q · filed 2019-09-12 | |
| 2019-04-30 | $24.14K 10-K · filed 2020-08-05 | |
| 2019-01-31 | $21.28K 10-Q · filed 2020-03-20 | |
| 2018-10-31 | $13.57K 10-Q · filed 2019-12-06 | |
| 2018-07-31 | $5.17K 10-Q · filed 2019-09-12 | |
| 2018-04-30 | $1.84K 10-K · filed 2019-07-30 | |
| 2017-04-30 | $2.44K 10-K · filed 2018-07-17 |